BE654702A - - Google Patents

Info

Publication number
BE654702A
BE654702A BE654702DA BE654702A BE 654702 A BE654702 A BE 654702A BE 654702D A BE654702D A BE 654702DA BE 654702 A BE654702 A BE 654702A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE654702A publication Critical patent/BE654702A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00—Speech recognition
    • G10L15/02—Feature extraction for speech recognition; Selection of recognition unit
    • G10L2015/022—Demisyllables, biphones or triphones being the recognition units
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BE654702D 1963-10-23 1964-10-22 BE654702A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB41842/63A GB1069437A (en) 1963-10-23 1963-10-23 Injectable x-ray contrast media
US34421364A 1964-02-12 1964-02-12

Publications (1)

Publication Number Publication Date
BE654702A true BE654702A (fr) 1965-02-15

Family

ID=26264759

Family Applications (1)

Application Number Title Priority Date Filing Date
BE654702D BE654702A (fr) 1963-10-23 1964-10-22

Country Status (13)

Country Link
US (1) US3347746A (fr)
AT (1) AT263997B (fr)
BE (1) BE654702A (fr)
BR (1) BR6463683D0 (fr)
CH (1) CH438584A (fr)
DE (1) DE1234931B (fr)
DK (1) DK109526C (fr)
FI (1) FI44670C (fr)
FR (1) FR3758M (fr)
GB (1) GB1069437A (fr)
IT (1) IT1044727B (fr)
NL (1) NL152753B (fr)
SE (1) SE303829C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855405A (en) * 1969-11-26 1974-12-17 Squibb & Sons Inc Radiographic contrast composition containing 2{40 ,6{40 -diiodo-dl-thyronine and methods of use thereof
US4278654A (en) * 1978-07-04 1981-07-14 Nyegaard & Co. A/S Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
GB2465663A (en) * 2008-11-26 2010-06-02 Ge Healthcare As X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2132351A (en) * 1934-07-14 1938-10-04 Winthrop Chem Co Inc Stable aqueous solutions of subtances having an anesthetic effect
US2268915A (en) * 1939-05-27 1942-01-06 Hahnemann Res Foundation Method and material for detoxifying local anesthetics
US2820814A (en) * 1955-03-21 1958-01-21 Schering Corp Polyiodinated 5-aminoisophthalic acids, salts, and esters
US3009952A (en) * 1957-04-17 1961-11-21 Sterling Drug Inc Preparation of halogenated isophthalic acids
US2921884A (en) * 1957-09-30 1960-01-19 Sterling Drug Inc Pharmaceutical compositions
US3033757A (en) * 1959-04-08 1962-05-08 Mallinckrodt Chemical Works X-ray contrast agents
US3175952A (en) * 1963-05-29 1965-03-30 Sterling Drug Inc Aqueous radiopaque solutions containing sodium and calcium ions

Also Published As

Publication number Publication date
FI44670C (fi) 1971-12-10
GB1069437A (en) 1967-05-17
BR6463683D0 (pt) 1973-07-17
DK109526C (da) 1968-05-06
IT1044727B (it) 1980-04-21
NL6412391A (fr) 1965-04-26
CH438584A (de) 1967-06-30
FI44670B (fr) 1971-08-31
AT263997B (de) 1968-08-12
US3347746A (en) 1967-10-17
SE303829C (sv) 1972-04-17
SE303829B (sv) 1968-09-09
FR3758M (fr) 1965-12-13
NL152753B (nl) 1977-04-15
DE1234931B (de) 1967-02-23

Similar Documents

Publication Publication Date Title
FI44670B (fr)
BE627012A (fr)
BE637284A (fr)
BE627025A (fr)
BE626915A (fr)
BE626867A (fr)
BE626826A (fr)
BE626803A (fr)
BE626590A (fr)
BE626358A (fr)
BE621232A (fr)
BE625880A (fr)
BE625828A (fr)
BE645599A (fr)
BE625825A (fr)
BE645546A (fr)
BE625136A (fr)
BE624982A (fr)
BE624811A (fr)
BE621517A (fr)
BE624070A (fr)
BE623490A (fr)
BE623315A (fr)
BE644909A (fr)
BE644734A (fr)